United States · FDA National Drug Code directory

Divalproex sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71610-289_214cf544-a872-5727-e063-6294a90a5843
Product NDC
71610-289
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
Divalproex sodium
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Marketing category
ANDA
Marketing start / end (source format)
20140602
Source listing expiry
20261231

Source-listed ingredients

  • DIVALPROEX SODIUM — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-289-30) · 71610-289-30
  • 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-289-60) · 71610-289-60
  • 150 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-289-75) · 71610-289-75
  • 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-289-80) · 71610-289-80
  • 270 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-289-92) · 71610-289-92

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Divalproex sodium — United States | Molindra Medicines